Bank of New York Mellon Corp lessened its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 2.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,103,583 shares of the company's stock after selling 21,984 shares during the quarter. Bank of New York Mellon Corp owned 1.19% of Acadia Healthcare worth $43,757,000 as of its most recent SEC filing.
A number of other hedge funds have also recently modified their holdings of the stock. Wellington Management Group LLP boosted its position in Acadia Healthcare by 12.2% in the 3rd quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company's stock worth $739,250,000 after purchasing an additional 1,266,384 shares in the last quarter. Holocene Advisors LP boosted its holdings in Acadia Healthcare by 201.5% during the third quarter. Holocene Advisors LP now owns 972,513 shares of the company's stock worth $61,667,000 after buying an additional 649,997 shares in the last quarter. JPMorgan Chase & Co. grew its position in Acadia Healthcare by 17.0% during the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock valued at $198,258,000 after buying an additional 454,044 shares during the period. Beach Point Capital Management LP purchased a new position in Acadia Healthcare in the fourth quarter valued at $14,097,000. Finally, Bank of Montreal Can raised its position in shares of Acadia Healthcare by 2,456.1% in the third quarter. Bank of Montreal Can now owns 324,569 shares of the company's stock worth $20,539,000 after acquiring an additional 311,871 shares during the period.
Acadia Healthcare Trading Down 2.3 %
NASDAQ ACHC traded down $0.70 on Monday, reaching $29.87. 1,844,154 shares of the company were exchanged, compared to its average volume of 1,878,131. Acadia Healthcare Company, Inc. has a fifty-two week low of $28.09 and a fifty-two week high of $82.40. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The business's fifty day moving average price is $41.32 and its 200 day moving average price is $50.05. The stock has a market capitalization of $2.78 billion, a P/E ratio of 9.79, a price-to-earnings-growth ratio of 1.46 and a beta of 1.38.
Analysts Set New Price Targets
ACHC has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a "hold" rating to a "buy" rating and lifted their price target for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. TD Cowen reduced their target price on Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating for the company in a research note on Tuesday, January 7th. Bank of America cut their price objective on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a research note on Friday, February 28th. KeyCorp decreased their target price on Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating on the stock in a research report on Monday, March 3rd. Finally, Cantor Fitzgerald reiterated a "neutral" rating and set a $52.00 price target on shares of Acadia Healthcare in a research report on Tuesday, December 10th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Acadia Healthcare has a consensus rating of "Hold" and an average target price of $56.31.
Check Out Our Latest Report on Acadia Healthcare
About Acadia Healthcare
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.